Franz Schuler

2.0k total citations
32 papers, 1.5k citations indexed

About

Franz Schuler is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Franz Schuler has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Organic Chemistry. Recurrent topics in Franz Schuler's work include Drug Transport and Resistance Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Synthesis and Catalytic Reactions (4 papers). Franz Schuler is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Synthesis and Catalytic Reactions (4 papers). Franz Schuler collaborates with scholars based in Switzerland, United States and Germany. Franz Schuler's co-authors include Holger Fischer, Björn Wagner, Klaus Müller, Erick M. Carreira, Mark Rogers‐Evans, Georg Wuitschik, Liudmila Polonchuk, I. Parrilla, Johannes A. Burkhard and Christoph Funk and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and ACS Nano.

In The Last Decade

Franz Schuler

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz Schuler Switzerland 17 677 536 234 167 138 32 1.5k
Daniel L. Flynn United States 30 1.3k 1.9× 1.2k 2.2× 146 0.6× 71 0.4× 245 1.8× 100 2.4k
Chunhao Yang China 29 1.4k 2.0× 745 1.4× 99 0.4× 363 2.2× 290 2.1× 136 2.4k
Sabine Hadidaꝉ United States 17 1.2k 1.7× 957 1.8× 164 0.7× 276 1.7× 54 0.4× 29 2.7k
Brian C. Shook United States 18 1.5k 2.3× 509 0.9× 81 0.3× 103 0.6× 88 0.6× 25 2.1k
Stephen W. Kaldor United States 20 1.4k 2.0× 1.2k 2.2× 151 0.6× 71 0.4× 310 2.2× 36 2.6k
Neelakandha S. Mani United States 24 1.4k 2.1× 893 1.7× 79 0.3× 77 0.5× 169 1.2× 75 2.9k
Pierfausto Seneci Italy 24 706 1.0× 1.2k 2.2× 124 0.5× 49 0.3× 147 1.1× 109 2.0k
John C. Hodges United States 23 1.0k 1.5× 1.3k 2.4× 135 0.6× 44 0.3× 107 0.8× 56 2.1k
Daniela Perrone Italy 27 824 1.2× 957 1.8× 85 0.4× 115 0.7× 156 1.1× 75 1.6k
Gregory J. Wells United States 22 971 1.4× 697 1.3× 58 0.2× 70 0.4× 108 0.8× 54 1.9k

Countries citing papers authored by Franz Schuler

Since Specialization
Citations

This map shows the geographic impact of Franz Schuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Schuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Schuler more than expected).

Fields of papers citing papers by Franz Schuler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Schuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Schuler. The network helps show where Franz Schuler may publish in the future.

Co-authorship network of co-authors of Franz Schuler

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Schuler. A scholar is included among the top collaborators of Franz Schuler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Schuler. Franz Schuler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leandro, Maria, Mark S. Cragg, Florian Kollert, et al.. (2024). P179 CD19hi B cells express T-bet and display activated metabolism and function in rheumatoid arthritis and systemic lupus erythematosus patient samples. Lara D. Veeken. 63(Supplement_1). 1 indexed citations
2.
Leandro, Maria, Mark S. Cragg, Florian Kollert, et al.. (2024). Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?. Clinical & Experimental Immunology. 217(1). 15–30. 15 indexed citations
3.
Liang, Xiaofei, et al.. (2024). Evaluations of an Early Change in Tumor Pathophysiology in Response to Radiotherapy with Oxygen Enhanced Electron Paramagnetic Resonance Imaging (OE EPRI). Molecular Imaging and Biology. 26(3). 448–458. 2 indexed citations
4.
Hänel, Gerulf, Koorosh Korfi, Sylvia Herter, et al.. (2023). Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific. Blood. 142(Supplement 1). 2058–2058. 1 indexed citations
5.
Fischer, Holger, Claudia Senn, Mohammed Ullah, et al.. (2020). Calculation of an Apical Efflux Ratio from P-Glycoprotein (P-gp) In Vitro Transport Experiments Shows an Improved Correlation with In Vivo Cerebrospinal Fluid Measurements in Rats: Impact on P-gp Screening and Compound Optimization. Journal of Pharmacology and Experimental Therapeutics. 376(3). 322–329. 9 indexed citations
6.
McAleer, Christopher W., Christopher J. Long, Daniel Elbrecht, et al.. (2019). Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics. Science Translational Medicine. 11(497). 141 indexed citations
7.
Schadt, Simone, Simon Hauri, Roland F. Staack, et al.. (2019). Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug Metabolism and Disposition. 47(12). 1443–1456. 32 indexed citations
8.
Giroud, Maude, Bernd Kuhn, Rainer E. Martin, et al.. (2018). 2H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design. Journal of Medicinal Chemistry. 61(8). 3370–3388. 44 indexed citations
9.
Kratochwil, Nicole A., Christophe Meille, Stephen Fowler, et al.. (2017). Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling. The AAPS Journal. 19(2). 534–550. 88 indexed citations
10.
Kroll, Katharina T., et al.. (2017). Electro-mechanical conditioning of human iPSC-derived cardiomyocytes for translational research. Progress in Biophysics and Molecular Biology. 130(Pt B). 212–222. 64 indexed citations
11.
12.
Davies, Mark, Ken Wang, Gary R. Mirams, et al.. (2016). Recent developments in using mechanistic cardiac modelling for drug safety evaluation. Drug Discovery Today. 21(6). 924–938. 48 indexed citations
13.
Brink, Andreas, Axel Pähler, Christoph Funk, Franz Schuler, & Simone Schadt. (2016). Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design. Drug Discovery Today. 22(5). 751–756. 30 indexed citations
14.
Jones, Russell G., Michael Keller, Na Qiu, et al.. (2015). Shedding light on minipig drug metabolism – elevated amide hydrolysisin vitro. Xenobiotica. 46(6). 483–494. 4 indexed citations
15.
Caruso, Antonello, Rubén Alvarez‐Sánchez, Alexander Hillebrecht, et al.. (2013). PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation. Biochemical Pharmacology. 85(11). 1684–1699. 24 indexed citations
16.
Poirier, Agnès, Sara Belli, Christoph Funk, et al.. (2012). Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies. Drug Metabolism and Disposition. 40(8). 1556–1565. 14 indexed citations
17.
Burkhard, Johannes A., Björn Wagner, Holger Fischer, et al.. (2010). Synthesis of Azaspirocycles and their Evaluation in Drug Discovery. Angewandte Chemie International Edition. 49(20). 3524–3527. 197 indexed citations
18.
Wuitschik, Georg, Mark Rogers‐Evans, Klaus Müller, et al.. (2006). Oxetanes as Promising Modules in Drug Discovery. Angewandte Chemie International Edition. 45(46). 7736–7739. 192 indexed citations
19.
Wuitschik, Georg, Mark Rogers‐Evans, Klaus Müller, et al.. (2006). Titelbild: Oxetanes as Promising Modules in Drug Discovery (Angew. Chem. 46/2006). Angewandte Chemie. 118(46). 7807–7807. 1 indexed citations
20.
Nicolaou, K. C., et al.. (2000). Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase. Chemistry & Biology. 7(12). 979–992. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel L. Flynn Breakdown of academic impact, for papers by Chunhao Yang Breakdown of academic impact, for papers by Sabine Hadidaꝉ Breakdown of academic impact, for papers by Brian C. Shook Breakdown of academic impact, for papers by Stephen W. Kaldor Breakdown of academic impact, for papers by Neelakandha S. Mani Breakdown of academic impact, for papers by Pierfausto Seneci Breakdown of academic impact, for papers by John C. Hodges Breakdown of academic impact, for papers by Daniela Perrone Breakdown of academic impact, for papers by Gregory J. Wells
Rankless by CCL
2026